NCT00539396View on ClinicalTrials.gov

A 3 Month, Randomized, Open Label, Multi-center Study of Technosphere/Insulin Compared to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Receiving Insulin Glargine

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

December 31, 2005

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Technosphere Insulin

Sponsors
All Listed Sponsors
lead

Mannkind Corporation

INDUSTRY